RecruitingNCT06504927
Biomarker Discovery in Lung Cancer - Malaysia
Sponsor
University of Malaya
Enrollment
400 participants
Start Date
Jan 16, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.
Eligibility
Min Age: 30 Years
Plain Language Summary
Simplified for easier understanding
This study in Malaysia is looking for a blood-based biomarker — a measurable signal in the blood — that can help detect lung cancer at an early stage. It focuses on people who already have lung-related conditions (like COPD or small lung nodules) but have not been diagnosed with lung cancer, to see if a blood test can provide early warning.
**You may be eligible if...**
- You are 30 years or older
- You have no previous history of any cancer
- You have COPD or small lung nodules (under 11mm) that don't require biopsy
- You are willing to provide blood samples and return for follow-up scans
- You can provide your X-ray or low-dose CT (LDCT) scan results
**You may NOT be eligible if...**
- You have received chemotherapy, radiotherapy, or any cancer treatment
- You are pregnant or breastfeeding
- You are unwilling to sign consent
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06504927
Related Trials
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT000018231 location
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)
NCT017865901 location
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
NCT051188542 locations
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
NCT053069121 location
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
NCT014876031 location